Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 50,474 | 47,462 | 45,271 | 38,815 | 46,056 |
| Cost of Goods | 2,733 | 3,440 | 3,460 | 3,063 | 3,499 |
| Gross Profit | 47,741 | 44,022 | 41,811 | 35,752 | 42,557 |
| Operating Expenses | 58,620 | 53,697 | 49,365 | 41,810 | 45,923 |
| Operating Income | -10,146 | -9,235 | -7,094 | -5,995 | -2,867 |
| Other Income | 4,630 | 4,571 | 5,433 | 5,875 | 5,459 |
| Pre-tax Income | -5,516 | -4,664 | -1,661 | -120 | 2,592 |
| Income Tax | -998 | -518 | 739 | -257 | 1,072 |
| Net Income Continuous | -4,518 | -4,146 | -2,400 | 137 | 1,520 |
| Net Income | $-4,518 | $-4,146 | $-2,400 | $137 | $1,520 |
| EPS Basic Total Ops | -0.08 | -0.07 | -0.05 | 0.00 | 0.03 |
| EPS Basic Continuous Ops | -0.08 | -0.07 | -0.04 | 0.00 | 0.03 |
| EPS Diluted Total Ops | -0.08 | -0.07 | -0.05 | 0.00 | 0.03 |
| EPS Diluted Continuous Ops | -0.08 | -0.07 | -0.04 | 0.00 | 0.03 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.07 | -0.04 | N/A | N/A |
| EBITDA(a) | $-10,214 | $-8,477 | $-7,682 | $-8,227 | $-4,218 |